Endurx Pharmaceuticals Inc - AZ Pima, Tucson 85704

Endurx Pharmaceuticals Inc entered the industry of Commercial Biotechnical Research in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact by calling (520) 300-8520 during business hours. You can also write to the business’ Single Location at 405 West Cool Drive # 107, Tucson, Arizona AZ 85704. You can also visit the company’s website at actusbiotech.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Endurx Pharmaceuticals Inc
Place of Business: 405 West Cool Drive # 107, Tucson, AZ 85704
Contact Number: (520) 300-8520
Website: actusbiotech.com
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2011
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Endurx Pharmaceuticals Inc is a company operating from Pima, Arizona providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2011 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Endurx Pharmaceuticals Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative at (520) 300-8520 for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 405 West Cool Drive # 107 in Tucson, Arizona 85704 and can be engaged online through the company website at actusbiotech.com, the company Twitter , and Facebook page .